Philip C. Calder mainly investigates Polyunsaturated fatty acid, Internal medicine, Biochemistry, Endocrinology and Eicosapentaenoic acid. His work carried out in the field of Polyunsaturated fatty acid brings together such families of science as Unsaturated fatty acid, Pregnancy, Inflammation, Arachidonic acid and Fish oil. His work deals with themes such as Placebo and Linoleic acid, which intersect with Internal medicine.
The study incorporates disciplines such as Food science and Disease in addition to Biochemistry. His study looks at the relationship between Endocrinology and fields such as Monocyte, as well as how they intersect with chemical problems. His biological study spans a wide range of topics, including Gastroenterology and Docosahexaenoic acid.
His primary areas of investigation include Internal medicine, Polyunsaturated fatty acid, Endocrinology, Docosahexaenoic acid and Eicosapentaenoic acid. Philip C. Calder combines subjects such as Gastroenterology, Pregnancy, Immune system and Linoleic acid with his study of Internal medicine. The Polyunsaturated fatty acid study combines topics in areas such as Arachidonic acid, Fish oil and Immunology.
His study in Endocrinology is interdisciplinary in nature, drawing from both Unsaturated fatty acid and Lymphocyte proliferation. His Docosahexaenoic acid study incorporates themes from Randomized controlled trial and Physiology. His Eicosapentaenoic acid study integrates concerns from other disciplines, such as Placebo and Pharmacology.
Internal medicine, Docosahexaenoic acid, Eicosapentaenoic acid, Endocrinology and Fish oil are his primary areas of study. In his research on the topic of Internal medicine, Placebo is strongly related with Gastroenterology. His Docosahexaenoic acid research is multidisciplinary, incorporating perspectives in Gestation, Immune system, Dietary Reference Intake and Lipoprotein.
His Eicosapentaenoic acid study is focused on Polyunsaturated fatty acid in general. His work in Endocrinology tackles topics such as Fatty acid which are related to areas like Arachidonic acid and Triglyceride. His Fish oil study combines topics in areas such as Food science, Emulsion, Oily fish, Coronavirus disease 2019 and Parenteral nutrition.
The scientist’s investigation covers issues in Docosahexaenoic acid, Internal medicine, Eicosapentaenoic acid, Inflammation and Immune system. Philip C. Calder has included themes like Placebo, Endocrinology and Neonatal intensive care unit in his Internal medicine study. His research in Endocrinology intersects with topics in Protein catabolism, Omega 3 fatty acid, Genotyping and Fatty acid.
Eicosapentaenoic acid is a subfield of Polyunsaturated fatty acid that Philip C. Calder explores. Philip C. Calder has researched Polyunsaturated fatty acid in several fields, including Randomized controlled trial, Physiology and Linoleic acid. His Inflammation research is multidisciplinary, incorporating elements of Cytokine storm, Breast milk and Disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Philip C Calder.
The American Journal of Clinical Nutrition (2006)
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
Colin Hill;Francisco Guarner;Gregor Reid;Glenn R. Gibson.
Nature Reviews Gastroenterology & Hepatology (2014)
ESPEN Guidelines on Parenteral Nutrition: intensive care.
Pierre Singer;Mette M. Berger;Greet Van den Berghe;Gianni Biolo.
Clinical Nutrition (2006)
Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance
Philip C. Calder.
Biochimica et Biophysica Acta (2015)
Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults.
Graham C. Burdge;Philip C. Calder.
Reproduction Nutrition Development (2005)
Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial
Frank Thies;Jennifer M C Garry;Parveen Yaqoob;Kittipan Rerkasem.
The Lancet (2003)
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Philip C. Calder.
British Journal of Clinical Pharmacology (2013)
Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group
Nicolaas E.P. Deutz;Jürgen M. Bauer;Rocco Barazzoni;Gianni Biolo.
Clinical Nutrition (2014)
ESPEN guideline on clinical nutrition in the intensive care unit
Pierre Singer;Annika Reintam Blaser;Mette Berger;Waleed Alhazzani.
Clinical Nutrition (2019)
Polyunsaturated fatty acids, inflammation, and immunity.
Philip C. Calder.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: